Skip to content

Study · Not a test of the peptide alone · 2003

2 results

[Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders].

Parfenov AI, Ruchkina IN

Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology1 Jan 2003Cited by 1 (Europe PMC)

PMID14556551 (opens in a new tab)PepBankPUB-14556551
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Gepon.

  1. 01HumanNot a test of Gepon aloneNon-randomized trialEfficacy outcome

    In patients with post-infection IBS, Heponum-containing complex therapy contributed to restoration of eubiosis.

    In plain wordsIn patients with post-infection IBS, complex therapy containing Heponum helped restore the bowel microbial balance.

    Peptide
    Gepon
    Outcome
    IncreaseRestoration of eubiosis
    Study

    n: not reported in source

    Outcome group
    Gastrointestinal protection · Gastrointestinal

    Source sentences

    Summary
    The promoter of local immunity Heponum contributes to the restoration of eubiosis and normalization of showings of the immune status in patients with post-infection IBS.
    1 context sentence
    Title · context
    [Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders].

    In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gepon.

  2. 02HumanNot a test of Gepon aloneNon-randomized trialEfficacy outcome

    In patients with post-infection IBS, Heponum-containing complex therapy contributed to normalization of immune status measures.

    In plain wordsIn patients with post-infection IBS, complex therapy containing Heponum helped normalize immune status measures.

    Peptide
    Gepon
    Outcome
    Not applicableNormalization of immune status
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The promoter of local immunity Heponum contributes to the restoration of eubiosis and normalization of showings of the immune status in patients with post-infection IBS.
    1 context sentence
    Title · context
    [Hepon, promoter of local immunity in the complex therapy of dysfunctional microflora in bowel disorders].

    In this study, Gepon was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Gepon.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    27 Oct 2026, 18:20 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:32 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.